JFLLIFEPharmaceuticals
JFL LIFE SCIENCES — Quarterly Results & Earnings
₹8.55
-4.32%
Profit Growth YoY35.86%Latest quarter
Sales Growth YoY-24.30%Latest quarter
Sales CAGR 5Y22.15%5 year compound
Profit CAGR 5Y63.14%5 year compound
📋
Quarterly Performance
YoY Profit Growth+35.86%
🔥 Exceptional growth
YoY Sales Growth-24.30%
🔴 Significant decline
OPM 5Y Average
10.19%Operating profit margin
EPS Growth 5Y
-14.56%Interest Coverage
5.40Higher = safer debt servicing
ROE
11.09%ROCE
15.81%💡
Growth Analysis
JFL LIFE SCIENCES reported YoY profit growth of 35.86% and revenue growth of -24.30% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 22.15% and profits at 63.14% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on JFL LIFE SCIENCES
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.